Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Cancer Genetics|January 31, 2021
Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3'UTR of the MSH6 geneGiulia Cini, Ileana Carnevali, Nora Sahnane, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
A pilot characterization of human lung NSCLC by protein pathway activation mappingAngela Zupa, Giuseppina Improta, Alessandra Silvestri, et al.Iscience|September 7, 2021
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosisKlara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.New Biotechnology|October 10, 2021
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodiesSara Mravinacova, Malin Jönsson, Wanda Christ, et al.Nature Communications|October 16, 2024
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19August F Jernbom, Lovisa Skoglund, Elisa Pin, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2011
Integrated analysis of unclassified variants in mismatch repair genesChiara Pastrello, Elisa Pin, Fabio Marroni, et al.International Journal of Molecular Sciences|October 28, 2023
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated VasculitisFederica Mescia, Shaghayegh Bayati, Elisabeth Brouwer, et al.International Journal of Cancer|August 7, 2012
MUTYH c.933+3A>C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated PolyposisElisa Pin, Chiara Pastrello, Rossella Tricarico, et al.The Journal of Infectious Diseases|May 12, 2021
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population SurveysHassan Alkharaan, Shaghayegh Bayati, Cecilia Hellström, et al.Ebiomedicine|August 14, 2021
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2Sebastian Havervall, Ulrika Marking, Nina Greilert-Norin, et al.Pageof 5